Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PALI compared with CNTX: revenue, margins and what each company keeps, and the suppliers and customers both name
PALI
Palisade Bio, Inc.
Change
Mkt cap
Revenue
Revenue
CNTX
Context Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PALI
Palisade Bio, Inc.
vs
CNTX
Context Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
PALI
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▲
+1.90%
—
CNTX
No earnings history for CNTX.
= implied
PALI realized, solid
CNTX realized, hatched
One scale, both sides: full bar = 2%
× = |realized| ÷ implied
Source: market data
PALI
Palisade Bio, Inc.
Change
1.14
▼
−2.14%
· post 1.14
Mkt cap
$196.9M
Revenue
$500,000
Q2 FY26
CNTX
Context Therapeutics Inc.
Change
0.19
▲
+3.41%
· post 0.19
Closed
Nov 6 '26
Mkt cap
$17.8M
Revenue
—
vs
Compare
Closed
Nov 6 '26
PALI
Palisade Bio, Inc.
vs
CNTX
Context Therapeutics Inc.
1.14
▼
−2.14%
post 1.14
Price
0.19
▲
+3.41%
post 0.19
$196.9M
Mkt cap
$17.8M
Q2 FY26
$500,000
Revenue
—
Change
Change
PALI
1.14
▼
−2.14%
vs
CNTX
0.19
▲
+3.41%
Closed
Nov 6 '26